Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification.

Lieve KV, van der Werf C, Kallas D, Denjoy I, Bos JM, Aiba T, Behr ER, van den Berg MP, Bergeman AT, Blom NA, Borggrefe M, Brugada R, Carrillo Mora LM, Chorin E, Crotti L, Davis A, Drago F, Dusi V, Extramiana F, Franciosi S, Giudicessi JR, González Llopis FÁ, Haugaa KH, van den Heuvel F, Horie M, Ingles J, Kammeraad J, Kannankeril PJ, Khan HR, Krahn AD, MacIntyre C, Maltret A, Marjamaa A, Ohno S, Peltenburg PJ, Perez GJ, Probst V, Roberts JD, Robyns T, Rootwelt-Norberg C, Roses I Noguer F, Roston TM, Rydberg A, Sacher F, Sarquella-Brugada G, Schwartz PJ, Semsarian C, Shimizu W, Starling L, Sumitomo N, Skinner JR, Tavacova T, Tfelt-Hansen J, Till JA, Yap SC, Wada Y, Wangüemert F, Zorio E, Ackerman MJ, Leenhardt A, Sanatani S, Tanck MW, Wilde AA

Open source

DOI: 10.1093/eurheartj/ehaf965
Published: 2026 Sep 2
Container: European heart journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehaf965,
  title = {Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification.},
  author = {Lieve KV and van der Werf C and Kallas D and Denjoy I and Bos JM and Aiba T and Behr ER and van den Berg MP and Bergeman AT and Blom NA and Borggrefe M and Brugada R and Carrillo Mora LM and Chorin E and Crotti L and Davis A and Drago F and Dusi V and Extramiana F and Franciosi S and Giudicessi JR and González Llopis FÁ and Haugaa KH and van den Heuvel F and Horie M and Ingles J and Kammeraad J and Kannankeril PJ and Khan HR and Krahn AD and MacIntyre C and Maltret A and Marjamaa A and Ohno S and Peltenburg PJ and Perez GJ and Probst V and Roberts JD and Robyns T and Rootwelt-Norberg C and Roses I Noguer F and Roston TM and Rydberg A and Sacher F and Sarquella-Brugada G and Schwartz PJ and Semsarian C and Shimizu W and Starling L and Sumitomo N and Skinner JR and Tavacova T and Tfelt-Hansen J and Till JA and Yap SC and Wada Y and Wangüemert F and Zorio E and Ackerman MJ and Leenhardt A and Sanatani S and Tanck MW and Wilde AA},
  year = {2026},
  journal = {European heart journal},
  doi = {10.1093/eurheartj/ehaf965},
  url = {https://doi.org/10.1093/eurheartj/ehaf965}
}

RIS

TY  - JOUR
TI  - Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification.
AU  - Lieve KV
AU  - van der Werf C
AU  - Kallas D
AU  - Denjoy I
AU  - Bos JM
AU  - Aiba T
AU  - Behr ER
AU  - van den Berg MP
AU  - Bergeman AT
AU  - Blom NA
AU  - Borggrefe M
AU  - Brugada R
AU  - Carrillo Mora LM
AU  - Chorin E
AU  - Crotti L
AU  - Davis A
AU  - Drago F
AU  - Dusi V
AU  - Extramiana F
AU  - Franciosi S
AU  - Giudicessi JR
AU  - González Llopis FÁ
AU  - Haugaa KH
AU  - van den Heuvel F
AU  - Horie M
AU  - Ingles J
AU  - Kammeraad J
AU  - Kannankeril PJ
AU  - Khan HR
AU  - Krahn AD
AU  - MacIntyre C
AU  - Maltret A
AU  - Marjamaa A
AU  - Ohno S
AU  - Peltenburg PJ
AU  - Perez GJ
AU  - Probst V
AU  - Roberts JD
AU  - Robyns T
AU  - Rootwelt-Norberg C
AU  - Roses I Noguer F
AU  - Roston TM
AU  - Rydberg A
AU  - Sacher F
AU  - Sarquella-Brugada G
AU  - Schwartz PJ
AU  - Semsarian C
AU  - Shimizu W
AU  - Starling L
AU  - Sumitomo N
AU  - Skinner JR
AU  - Tavacova T
AU  - Tfelt-Hansen J
AU  - Till JA
AU  - Yap SC
AU  - Wada Y
AU  - Wangüemert F
AU  - Zorio E
AU  - Ackerman MJ
AU  - Leenhardt A
AU  - Sanatani S
AU  - Tanck MW
AU  - Wilde AA
PY  - 2026
JO  - European heart journal
DO  - 10.1093/eurheartj/ehaf965
UR  - https://doi.org/10.1093/eurheartj/ehaf965
ER  -

APA

KV, L., C, V. D. W., D, K., I, D., JM, B., T, A., ER, B., MP, V. D. B., AT, B., NA, B., M, B., R, B., LM, C. M., E, C., L, C., A, D., F, D., V, D., F, E., S, F., JR, G., FÁ, G. L., KH, H., F, V. D. H., M, H., J, I., J, K., PJ, K., HR, K., AD, K., C, M., A, M., A, M., S, O., PJ, P., GJ, P., V, P., JD, R., T, R., C, R., F, R. I. N., TM, R., A, R., F, S., G, S., PJ, S., C, S., W, S., L, S., N, S., JR, S., T, T., J, T., JA, T., SC, Y., Y, W., F, W., E, Z., MJ, A., A, L., S, S., MW, T., & AA, W. (2026). Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification.. European heart journal. https://doi.org/10.1093/eurheartj/ehaf965

Source records

pubmed · retrieved 2026-09-25T18:35:05.939Z